Skip to main content

Table 2 Quality assessment of eligible studies Newcastle–Ottawa scale (NOS) score

From: High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis

Author

Country

Selection

Comparability

Outcome

Total

Adequate of case definition

Representativeness of the cases

Selection of Controls

Definition of Controls

Comparability of cases and controls

Ascertainment of exposure

Same method of ascertainment

Non-Response rate

Wei L 2019

China

*

*

*

*

*

*

*

*

8a

Cui Y 2017

China

*

*

*

*

*

*

*

*

8a

Li XM 2020

China

*

*

*

*

*

-

*

*

7c

Zhang HY 2017

China

*

*

*

*

*

-

*

*

7c

Li CL 2019

China

*

*

*

*

*

*

*

-

7c

Yang XH 2021

China

*

*

*

*

*

*

*

-

7c

Kang BJ 2021

China

*

*

*

*

*

*

*

-

7c

Zhao LJ 2021

China

*

*

*

*

*

*

*

-

7c

Shi JD 2019

China

*

*

*

*

*

*

*

*

8a

Zhao SS 2020

China

*

*

*

*

*

*

*

-

7b

Wang F 2021

China

*

*

*

*

*

*

*

*

8a

Gao N 2020

China

*

*

*

*

*

*

-

-

6ab

Dong Z 2020

China

*

*

*

*

*

-

*

-

6abd

Geng H 2020

China

*

*

*

*

*

*

*

*

8a

Liang R 2018

China

*

*

*

*

*

*

*

*

8a

Pang LL 2019

China

*

*

*

*

*

*

*

-

7c

Li LP 2020

China

*

*

*

*

*

-

*

-

6bd

Chen CH 2018

China

*

*

*

*

*

*

*

*

8a

Wang RX 2020

China

*

*

*

*

*

-

*

-

6bd

Liu SX 2019

China

*

*

*

*

*

*

*

*

8a

Huang YS 2022

China

*

*

*

*

*

*

*

*

8a

Wang Y 2019

China

*

*

*

*

*

*

-

-

6bd

Wang S 2018

China

*

*

*

*

*

-

*

-

6bd

Guo LF 2018

China

*

*

*

*

*

*

*

-

7c

Huang YF 2021

China

*

*

*

*

*

*

*

*

8a

Zhang NN 2021

China

*

*

*

*

*

*

*

*

8a

Chen XL 2020

China

*

*

*

*

*

*

*

*

8a

Ma XR 2019

China

*

*

*

*

*

*

*

*

8a

Dong YZ 2018

China

*

*

*

*

*

-

*

-

6ad

Cui HX 2018

China

*

*

*

*

*

*

*

*

8a

Han PF 2021

China

*

*

*

*

**

*

*

*

9

Jin B 2018

China

*

*

*

*

*

*

*

*

8a

Li Y 2022

China

*

*

*

*

*

*

*

-

7cd

Han W 2018

China

*

*

*

*

**

*

*

*

9

Zhang ZW 2021

China

*

*

*

*

*

*

*

*

8a

Fan HJ 2021

China

*

*

*

*

**

*

*

*

9

Jin LL 2019

China

*

*

*

*

*

-

*

-

6bd

Chen ZY 2017

China

*

*

*

*

*

*

*

*

8a

Wang XL 2020

China

*

*

*

*

*

*

*

-

7cd

  1. aOnly univariate analysis was performed, and data for multivariate analysis were lacking
  2. bThe article only provides data on survival prognosis and does not provide clinical pathological parameters
  3. cLack of data on survival prognosis, only clinicopathological parameters were provided
  4. dFewer cases